APA (2013) Diagnostic and statistical manual of mental disorders, 5th ed

Jafari F, Abbasi P, Rahmati M, Hodhodi T, Kazeminia M (2022) Systematic review and Meta-analysis of Tourette Syndrome Prevalence; 1986 to 2022. Pediatr Neurol 137:6–16

Article  PubMed  Google Scholar 

WHO ICD-11: International classification of diseases (11th revision)2022

Kumar A, Trescher W, Byler D (2016) Tourette Syndrome and Comorbid Neuropsychiatric conditions. Curr Dev Disord Rep 3(4):217–221

Article  PubMed  PubMed Central  Google Scholar 

Lee WT, Huang HL, Wong LC, Weng WC, Vasylenko T, Jong YJ et al (2017) Tourette Syndrome as an independent risk factor for subsequent Sleep disorders in children: a Nationwide Population-based case-control study. Sleep. 40(3)

Set KK, Warner JN (2021) Tourette syndrome in children: an update. Curr Probl Pediatr Adolesc Health Care 51(7):101032

PubMed  Google Scholar 

Pringsheim T, Okun MS, Müller-Vahl K, Martino D, Jankovic J, Cavanna AE et al (2019) Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 92(19):896–906

Article  PubMed  PubMed Central  Google Scholar 

Müller-Vahl KR, Szejko N, Verdellen C, Roessner V, Hoekstra PJ, Hartmann A et al (2022) European clinical guidelines for Tourette syndrome and other tic disorders: summary statement. Eur Child Adolesc Psychiatry 31(3):377–382

Article  PubMed  Google Scholar 

Andrén P, Jakubovski E, Murphy TL, Woitecki K, Tarnok Z, Zimmerman-Brenner S et al (2022) European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions. Eur Child Adolesc Psychiatry 31(3):403–423

Article  PubMed  Google Scholar 

Roessner V, Eichele H, Stern JS, Skov L, Rizzo R, Debes NM et al (2022) European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. Eur Child Adolesc Psychiatry 31(3):425–441

Article  PubMed  Google Scholar 

Sallee F, Kohegyi E, Zhao J, McQuade R, Cox K, Sanchez R et al (2017) Randomized, Double-Blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette’s disorder in children and adolescents. J Child Adolesc Psychopharmacol 27(9):771–781

Article  PubMed  PubMed Central  Google Scholar 

Frey J, Malaty IA (2022) Tourette Syndrome Treatment Updates: a review and discussion of the current and upcoming literature. Curr Neurol Neurosci Rep 22(2):123–142

Article  PubMed  PubMed Central  Google Scholar 

WHO https://trialsearch.who.int 2024

NIH https://www.clinicaltrials.gov 2024

Seideman MF, Seideman TA (2020) A review of the current treatment of Tourette Syndrome. J Pediatr Pharmacol Ther 25(5):401–412

PubMed  PubMed Central  Google Scholar 

Ueda K, Black KJ (2021) A Comprehensive Review of Tic disorders in Children. J Clin Med. 10(11)

Kanaan AS, Gerasch S, García-García I, Lampe L, Pampel A, Anwander A et al (2017) Pathological glutamatergic neurotransmission in Gilles De La Tourette syndrome. Brain 140(1):218–234

Article  PubMed  Google Scholar 

Nikolaus S, Mamlins E, Antke C, Dabir M, Müller HW, Giesel FL (2022) Boosted dopamine and blunted serotonin in Tourette syndrome - evidence from in vivo imaging studies. Rev Neurosci 33(8):859–876

Article  PubMed  Google Scholar 

Mahone EM, Puts NA, Edden RAE, Ryan M, Singer HS (2018) GABA and glutamate in children with Tourette syndrome: A (1)H MR spectroscopy study at 7T. Psychiatry Res Neuroimaging 273:46–53

Article  PubMed  Google Scholar 

Rapanelli M, Pittenger C (2016) Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions. Neuropharmacology 106:85–90

Article  PubMed  Google Scholar 

Müller-Vahl KR, Bindila L, Lutz B, Musshoff F, Skripuletz T, Baumgaertel C et al (2020) Cerebrospinal fluid endocannabinoid levels in Gilles De La Tourette syndrome. Neuropsychopharmacology: Official Publication Am Coll Neuropsychopharmacol 45(8):1323–1329

Article  Google Scholar 

Augustine F, Singer HS (2018) Merging the pathophysiology and pharmacotherapy of tics. Tremor Other Hyperkinet Mov (N Y) 8:595

Article  PubMed  Google Scholar 

Gilbert DL, Budman CL, Singer HS, Kurlan R, Chipkin RE (2014) A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome. Clin Neuropharmacol 37(1):26–30

Article  PubMed  Google Scholar 

Gilbert DL, Murphy TK, Jankovic J, Budman CL, Black KJ, Kurlan RM et al (2018) Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: a randomized, placebo-controlled crossover study. Mov Disord 33(8):1272–1280

Article  PubMed  Google Scholar 

Gilbert DL, Dubow JS, Cunniff TM, Wanaski SP, Atkinson SD, Mahableshwarkar AR (2023) Ecopipam for Tourette Syndrome: a Randomized Trial. Pediatrics. 151(2)

Garibaldi G, Lasser R, Mueller-Vahl K (2024) Results of ALLEVIA 1, a phase 2a study exploring safety and tolerability of NOE-105 in patients with Tourette Syndrome. MDS Congress; September 27 - October 1, 2024; Philadelphia, PA, USA2024.

Marshall RD, Menniti FS, Tepper MA (2024) A novel PDE10A inhibitor for Tourette Syndrome and Other Movement disorders. Cells. 13(14)

Milosev LM, Psathakis N, Szejko N, Jakubovski E, Müller-Vahl KR (2019) Treatment of Gilles De La Tourette syndrome with Cannabis-Based Medicine: results from a retrospective analysis and online survey. Cannabis Cannabinoid Res 4(4):265–274

Article  PubMed  PubMed Central  Google Scholar 

Müller-Vahl KR (2024) Cannabinoids in the treatment of selected Mental illnesses: practical Approach and Overview of the literature. Pharmacopsychiatry 57(3):104–114

Article  PubMed  PubMed Central  Google Scholar 

Blest-Hopley G, Colizzi M, Giampietro V, Bhattacharyya S (2020) Is the adolescent brain at Greater vulnerability to the effects of Cannabis? A narrative review of the evidence. Front Psychiatry 11:859

Article  PubMed  PubMed Central  Google Scholar 

Jankovic J, Coffey B, Claassen DO, Jimenez-Shahed J, Gertz BJ, Garofalo EA et al (2021) Safety and efficacy of flexible-dose deutetrabenazine in children and adolescents with Tourette Syndrome: a Randomized Clinical Trial. JAMA Netw Open 4(10):e2128204

Article  PubMed  PubMed Central  Google Scholar 

Farber RH, Angelov A, Kim K, Carmack T, Thai-Cuarto D, Roberts E (2021) Clinical development of valbenazine for tics associated with Tourette syndrome. Expert Rev Neurother 21(4):393–404

Article  PubMed  Google Scholar 

Steeves T, McKinlay BD, Gorman D, Billinghurst L, Day L, Carroll A et al (2012) Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry Revue canadienne de psychiatrie 57(3):144–151

Article  PubMed  Google Scholar 

Singer HS, McDermott S, Ferenc L, Specht M, Mahone EM (2020) Efficacy of Parent-Delivered, Home-based therapy for tics. Pediatr Neurol 106:17–23

Article  PubMed  Google Scholar 

Andrén P, Aspvall K, de la Fernández L, Wiktor P, Romano S, Andersson E et al (2019) Therapist-guided and parent-guided internet-delivered behaviour therapy for paediatric Tourette’s disorder: a pilot randomised controlled trial with long-term follow-up. BMJ open 9(2):e024685

Article  PubMed  PubMed Central  Google Scholar 

Conelea CA, Wellen BCM (2017) Tic Treatment goes tech: a review of TicHelper.com. Cogn Behav Pract 24(3):374–381

Article  PubMed  PubMed Central  Google Scholar 

Prato A, Maugeri N, Chiarotti F, Morcaldi L, Vicario CM, Barone R et al (2022) A Randomized Controlled Trial Comparing Videoconference vs. Face-to-Face Delivery of Behavior Therapy for Youths With Tourette Syndrome in the Time of COVID-19. Front Psychiatry. 13:862422

Jakubovski E, Reichert C, Karch A, Buddensiek N, Breuer D, Müller-Vahl K (2016) The ONLINE-TICS study protocol: a Randomized Observer-Blind Clinical Trial to demonstrate the efficacy and safety of internet-delivered behavioral treatment for adults with chronic Tic disorders. Front Psychiatry 7:119

Article  PubMed  PubMed Central  Google Scholar 

Reese HE, Vallejo Z, Rasmussen J, Crowe K, Rosenfield E, Wilhelm S (2015) Mindfulness-based stress reduction for Tourette Syndrome and chronic tic disorder: a pilot study. J Psychosom Res 78(3):293–298

Article  PubMed  Google Scholar 

Xu W, Zhang C, Deeb W, Patel B, Wu Y, Voon V et al (2020) Deep brain stimulation for Tourette’s syndrome. Transl Neurodegener 9:4

Article  PubMed  PubMed Central  Google Scholar 

Lin X, Lin F, Chen H, Weng Y, Wen J, Ye Q et al (2022) Comparison of efficacy of deep brain stimulation, repeat transcranial magnetic stimulation, and behavioral therapy in Tourette syndrome: a systematic review and Bayesian Network Meta-Analysis. Heliyon 8(10):e10952

Article  PubMed  PubMed Central